130 related articles for article (PubMed ID: 33705812)
21. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.
Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X
Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389
[TBL] [Abstract][Full Text] [Related]
22. Identification of differentially expressed microRNAs in metastatic melanoma using next-generation sequencing technology.
Qi M; Huang X; Zhou L; Zhang J
Int J Mol Med; 2014 May; 33(5):1117-21. PubMed ID: 24573402
[TBL] [Abstract][Full Text] [Related]
23. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro.
Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S
Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686
[TBL] [Abstract][Full Text] [Related]
25. Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.
Xu X; Jia R; Zhou Y; Song X; Wang J; Qian G; Ge S; Fan X
Int J Oncol; 2011 May; 38(5):1385-93. PubMed ID: 21373755
[TBL] [Abstract][Full Text] [Related]
26. The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
Örs Kumoğlu G; Döşkaya M; Gulce Iz S
Gene; 2019 Aug; 710():341-353. PubMed ID: 31195093
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.
Joshi P; Seki T; Kitamura S; Bergano A; Lee B; Perera RJ
RNA Biol; 2019 Oct; 16(10):1355-1363. PubMed ID: 31179855
[TBL] [Abstract][Full Text] [Related]
28. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
[TBL] [Abstract][Full Text] [Related]
29. Hypoxic Melanoma Cells Deliver microRNAs to Dendritic Cells and Cytotoxic T Lymphocytes through Connexin-43 Channels.
Tittarelli A; Navarrete M; Lizana M; Hofmann-Vega F; Salazar-Onfray F
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066331
[TBL] [Abstract][Full Text] [Related]
30. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
Ono S; Oyama T; Lam S; Chong K; Foshag LJ; Hoon DS
Oncotarget; 2015 Mar; 6(9):7053-64. PubMed ID: 25749524
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
Kim JH; Ahn JH; Lee M
Cancer Res Treat; 2017 Oct; 49(4):947-959. PubMed ID: 28052651
[TBL] [Abstract][Full Text] [Related]
32. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
Caporali S; Amaro A; Levati L; Alvino E; Lacal PM; Mastroeni S; Ruffini F; Bonmassar L; Antonini Cappellini GC; Felli N; Carè A; Pfeffer U; D'Atri S
J Exp Clin Cancer Res; 2019 Jun; 38(1):272. PubMed ID: 31227006
[TBL] [Abstract][Full Text] [Related]
33. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
34. Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells.
Kozar I; Cesi G; Margue C; Philippidou D; Kreis S
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2980-2992. PubMed ID: 28408301
[TBL] [Abstract][Full Text] [Related]
35. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.
Wang W; Liu M; Guan Y; Wu Q
Med Sci Monit; 2016 Jun; 22():2126-32. PubMed ID: 27327120
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
38. Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7.
Yue X; Lan F; Xia T
Mol Ther; 2019 Nov; 27(11):1939-1949. PubMed ID: 31402274
[TBL] [Abstract][Full Text] [Related]
39. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.
Mueller DW; Rehli M; Bosserhoff AK
J Invest Dermatol; 2009 Jul; 129(7):1740-51. PubMed ID: 19212343
[TBL] [Abstract][Full Text] [Related]
40. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
